Brooks Wiley
Psychiatric/Mental Health · St George, UTNPI 1003267923
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 150 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations.
Across 150 payments — averaging $19.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$572
- Neurocrine Biosciences, Inc.$270
- Corium, LLC$224
- Teva Pharmaceuticals USA, Inc.$190
- Ironshore Pharmaceuticals Inc.$173
- Johnson & Johnson$168
- plus $1K from 22 others
What the payments were for
- Food & beverage$2,927100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 35 | $572 |
| Neurocrine Biosciences, Inc. | 13 | $270 |
| Corium, LLC | 13 | $224 |
| Teva Pharmaceuticals USA, Inc. | 11 | $190 |
| Ironshore Pharmaceuticals Inc. | 9 | $173 |
| Johnson & Johnson | 9 | $168 |
| Axsome Therapeutics, Inc. | 7 | $159 |
| Supernus Pharmaceuticals, Inc. | 5 | $152 |
| Lundbeck LLC | 6 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $91 |
| Alkermes, Inc. | 5 | $85 |
| Braeburn Inc. | 4 | $83 |
| Otsuka America Pharmaceutical, Inc. | 3 | $78 |
| Vanda Pharmaceuticals Inc. | 2 | $71 |
| Indivior Inc. | 3 | $63 |
| Collegium Pharmaceutical, Inc. | 3 | $61 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $54 |
| Tempus AI, Inc | 2 | $51 |
| Biogen | 2 | $43 |
| E.r. Squibb & Sons, L.L.C. | 2 | $39 |
| Adlon Therapeutics L.p. | 2 | $31 |
| Alfasigma USA, Inc. | 1 | $30 |
| Biohaven Pharmaceuticals, Inc. | 1 | $27 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $20 |
| Tris Pharma Inc | 1 | $20 |
| Almatica Pharma LLC | 1 | $18 |
| Merck | 1 | $14 |
How this compares
$2,927 in reported general payments places this provider in the 85th percentile of 393 psychiatric/mental health providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 25 | $5,729 |
| Buprenorphine Hcl | 32 | $2,920 |
| Lisdexamfetamine Dimesylate | 16 | $2,728 |
| Bupropion XlBupropion Hcl | 112 | $1,617 |
| Lurasidone Hcl | 27 | $1,482 |
| Methylphenidate ErMethylphenidate Hcl | 14 | $1,149 |
| Clonazepam | 61 | $1,116 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 36 | $1,092 |
| Quetiapine Fumarate | 80 | $1,052 |
| Alprazolam | 72 | $1,028 |
| Trazodone Hcl | 79 | $949 |
| Gabapentin | 42 | $907 |
| Tizanidine Hcl | 13 | $886 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 34 | $645 |
| Fluoxetine Hcl | 80 | $642 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $18 | $51499 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 393 psychiatric/mental health providers in Utah.
Other psychiatric/mental health in St George
- Nicole CumminsSt George$4K
- Maryellen LangleySt George$3K
- Bret HafenLayton$381K
- Alberto SouzaSaint George$114K
- Anthony BrowningOrem$32K
- Debra HainRiverton$29K
- Kristin BarberSalt Lake City$28K
- Briana TerrySalt Lake City$14K
- Paige MarshallSaint George$13K
- Derick MoodySpringville$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.